GNI Group Ltd

3G6

Company Profile

  • Business description

    GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

  • Contact

    Shinjuku Park Tower
    3-7-1 Nishi-Shinjuku
    Shinjuku-ku
    Tokyo163-1030
    JPN

    T: +81 353263097

    http://www.gnipharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    896

Stocks News & Analysis

stocks

Oracle shares are up 87% in 2025. Is it a buy?

Oracle’s cloud database business is riding the AI wave.
stocks

Bumper crop to benefit ASX listed share

We raise our earnings forecast 11% for next year.
stocks

Is there a long-term buying opportunity in luxury stocks?

Our analysts think the recent wobble in revenue growth is cyclical, not structural.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.1011.700.13%
CAC 407,830.1123.48-0.30%
DAX 4023,527.05112.36-0.48%
Dow JONES (US)46,381.5466.270.14%
FTSE 1009,226.6810.010.11%
HKSE26,344.14200.96-0.76%
NASDAQ22,788.98157.500.70%
Nikkei 22545,493.66447.850.99%
NZX 50 Index13,126.6114.93-0.11%
S&P 5006,693.7529.390.44%
S&P/ASX 2008,810.9011.400.13%
SSE Composite Index3,828.588.490.22%

Market Movers